Madison Square Garden Sports
MSGS
404.97
+2.90
+0.72%
Madison Square Garden Sports
US · MSGS
#1487 by market cap
Listed 1970
404.97
+2.90
+0.72%
Live - 5344 symbols - heartbeat 305s ago
· 2026-10-07 19:54
After-hours
405.49
+0.13%
- Market cap
- 9.75B
- P/E (TTM)i
- 1,265.53
- P/Bi
- -37.04
- EPSi
- 0.32
- Div yieldi
- 0.00%
- 52W posi
- 85%
Reader sentiment
Are you bullish or bearish on MSGS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.70, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +11.03% YoY
Margins
- Gross margin
- 27.74%
- Operating margin
- 2.68%
- Net margin
- 0.67%
Key ratios & quality
- Enterprise valuei
- 9.90B
- Altman Z-Scorei
- 3.70
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 729.40M | 603.32M | 415.72M | 821.35M | 887.45M | 1.03B | 1.04B | 1.15B |
| Gross profit | 289.32M | 243.35M | 133.83M | 320.79M | 338.64M | 410.64M | 284.10M | 320.12M |
| Selling & admin expenses | 327.44M | 319.68M | 206.70M | 229.67M | 249.89M | 261.43M | 266.08M | 286.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -58.20M | -93.87M | -78.44M | 86.08M | 85.17M | 146.04M | 14.81M | 30.95M |
| Pretax profit | -60.64M | -98.05M | -89.32M | 73.93M | 89.92M | 105.67M | -17.27M | 17.98M |
| Tax | -12.62M | 20.59M | -73.42M | 25.05M | 44.29M | 46.90M | 5.17M | 10.22M |
| Net profit | -3.12M | -208.86M | -15.90M | 48.88M | 45.63M | 58.77M | -22.44M | 7.76M |
| Basic EPS | 0 | -8 | -1 | 2 | 2 | 2 | -1 | 0 |
| Diluted EPS | 0.48 | -7.62 | -0.58 | 2.10 | 1.89 | 2.44 | -0.93 | 0.32 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 424.20M | 203.96M | 39.45M | 403.42M | 432.20M | 278.75M |
| Gross profit | 107.86M | 49.14M | 31.18M | 92.04M | 77.70M | 119.21M |
| Selling & admin expenses | 74.70M | 70.89M | 57.79M | 69.07M | 73.70M | 85.44M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 32.34M | -22.58M | -27.43M | 22.18M | 3.21M | 32.98M |
| Pretax profit | 22.63M | -27.12M | -17.35M | 14.96M | -13.29M | 33.67M |
| Tax | 36.86M | -25.34M | -8.56M | 6.72M | 6.69M | 5.37M |
| Net profit | -14.23M | -1.78M | -8.80M | 8.24M | -19.98M | 28.30M |
| Basic EPS | -1 | 0 | 0 | 0 | -1 | 1 |
| Diluted EPS | -0.59 | -0.07 | -0.37 | 0.34 | -0.83 | 1.16 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.41B | 128.28M | 185.25M | 205.27M | 149.23M | 216.94M | 251.10M | 323.29M |
| Cash & ST investments | 4.32M | 77.85M | 64.90M | 91.02M | 40.40M | 89.14M | 144.62M | 164.51M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 3.76B | 1.23B | 1.31B | 1.30B | 1.32B | 1.35B | 1.47B | 1.54B |
| Total current liabilities | 760.02M | 290.25M | 368.28M | 438.30M | 520.53M | 521.98M | 563.52M | 642.44M |
| Short-term debt | -- | 39.13M | 71.95M | 73.70M | 79.75M | 80.27M | 76.62M | 74.33M |
| Long-term debt | -- | 350.00M | 355.00M | 220.00M | 295.00M | 275.00M | 267.00M | 242.00M |
| Total liabilities | 1,057,403,000.00 | 1,437,233,000.00 | 1,511,805,000.00 | 1,447,343,000.00 | 1,652,251,000.00 | 1,612,602,000.00 | 1,754,413,000.00 | 1,800,948,000.00 |
| Total equity | 2.71B | -203.44M | -201.87M | -145.38M | -337.23M | -266.31M | -281.44M | -263.30M |
| Retained earnings | 29.00M | -43.61M | -78.90M | -35.70M | -173.91M | -115.14M | -137.60M | -129.86M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 319.29M | 251.10M | 246.69M | 299.56M | 295.56M | 323.29M |
| Cash & ST investments | 96.54M | 144.62M | 48.63M | 81.30M | 107.04M | 164.51M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.50B | 1.47B | 1.52B | 1.54B | 1.51B | 1.54B |
| Total current liabilities | 617.19M | 563.52M | 637.32M | 641.61M | 637.81M | 642.44M |
| Short-term debt | 75.02M | 76.62M | 78.23M | 79.88M | 73.49M | 74.33M |
| Long-term debt | 267.00M | 267.00M | 267.00M | 267.00M | 242.00M | 242.00M |
| Total liabilities | 1,787,947,000.00 | 1,754,413,000.00 | 1,811,580,000.00 | 1,826,820,000.00 | 1,804,797,000.00 | 1,800,948,000.00 |
| Total equity | -283.45M | -281.44M | -294.18M | -282.08M | -295.45M | -263.30M |
| Retained earnings | -135.82M | -137.60M | -146.41M | -138.18M | -158.16M | -129.86M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 161.25M | 3.57M | -35.33M | 178.06M | 152.47M | 92.13M | 91.61M | 62.66M |
| Depreciation & amortization | 119.19M | 93.36M | 5.57M | 5.04M | 3.58M | 3.16M | 3.22M | 3.18M |
| Free cash flow | -27.58M | -358.91M | -35.79M | 177.12M | 151.29M | 90.68M | 87.99M | 61.26M |
| Dividends paid | -- | -- | 0 | 0 | -170.92M | -701.00K | -633.00K | -472.00K |
| Stock buybacks / issuance | 0 | 0 | 0 | 0 | -75.06M | -- | -- | -- |
| Ending cash balance | 1.12B | 90.67M | 72.04M | 91.02M | 40.46M | 94.91M | 153.19M | 164.51M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 6.26M | 49.72M | -84.95M | 32.45M | 57.52M | 57.65M |
| Depreciation & amortization | 823.00K | 822.00K | 811.00K | 790.00K | 790.00K | 788.00K |
| Free cash flow | 3.91M | 49.35M | -85.33M | 31.59M | 57.38M | 57.62M |
| Dividends paid | -33.00K | 0 | -340.00K | -132.00K | 0 | 0 |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 105.04M | 153.19M | 57.28M | 81.30M | 107.04M | 164.51M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 0.44 | -15.11 | -- | -- | -- | -- | -- | -- |
| ROA %i | 0.30 | -7.30 | -1.10 | 3.92 | 3.65 | 4.42 | -1.59 | 0.51 |
| ROIC %i | 0.16 | -10.16 | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -0.83 | -3.18 | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 1.14 | -15.51 | -18.94 | 10.43 | 12.71 | 12.97 | 0.42 | 3.39 |
| FCF / sales %i | -- | -- | -- | 21.56 | 17.05 | 8.83 | 8.47 | 5.31 |
| Current ratioi | 1.86 | 0.44 | 0.50 | 0.47 | 0.29 | 0.42 | 0.45 | 0.50 |
| Quick ratioi | 0.03 | 0.29 | 0.40 | 0.38 | 0.19 | 0.30 | 0.31 | 0.39 |
| Debt / assetsi | 0.00 | 86.58 | 85.36 | 76.29 | 85.26 | 82.09 | 80.43 | 75.46 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 0.91 | -20.98 | -7.46 | 7.30 | 4.93 | 4.83 | 0.20 | 1.85 |
| Revenue CAGR (3Y) %i | -13.20 | -22.94 | -16.44 | 4.04 | 13.73 | 35.19 | 8.16 | 9.14 |
| Net income CAGR (3Y) %i | -- | -- | -- | 64.78 | -- | -- | -- | -45.45 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -20.80 | -26.02 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | 0.33 | -1.59 | -1.64 | -1.12 | -1.48 | 0.51 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.11 | 0.42 | 0.11 | 1.39 | -1.96 | 3.39 |
| FCF / sales %i | 13.80 | 8.47 | 2.85 | -- | 4.91 | 5.31 |
| Current ratioi | 0.52 | 0.45 | 0.39 | 0.47 | 0.46 | 0.50 |
| Quick ratioi | 0.38 | 0.31 | 0.19 | 0.30 | 0.31 | 0.39 |
| Debt / assetsi | 79.13 | 80.43 | 77.41 | 76.90 | 77.37 | 75.46 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 3.29 | 0.20 | 0.05 | 0.68 | -0.98 | 1.85 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Event-related is the largest reported line at 46.50% of revenue, across 4 reported segments.
- Media rights follows at 25.63%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Event-related46.50%
Media rights25.63%
Sponsorship, signage and suite licenses22.13%
League distributions and other5.74%
Region
United States100.00%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.